Bioconjugation Market Bioconjugation Market Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Bioconjugation Market by Product ...
In a deal valued at up to $1 billion, Roche has licensed rights to a DLL3-directed antibody-drug conjugate (ADC) from China's ...
Moreover, the presence of prominent industry players such as AbbVie Inc., Johnson & Johnson, and Alcon Inc. strengthens North America's market position, driving further growth and fostering continuous ...